News

Announcement Follows FDA 510(k) Clearance of Device

New guidance outlines best practices for clinicians and promotes shared decision- making for a high-risk patient population.

Results show potential to monitor ECG data in a non-clinical setting.

Cardioneural ablation could replace need for pacemaker in young patients with vasovagal syncope and episodes of slow heart rate.

Three new studies highlight the potential benefits of His bundle and left bundle branch area pacing compared to biventricular pacing

FDA-cleared HeartKey® 2.0 launches to power next generation of medical and consumer devices and platforms

admIRE study will evaluate safety and effectiveness of investigational Pulse Field Ablation (PFA) technologies in treating symptomatic drug refractory recurrent intermittent atrial fibrillation

- Patients successfully self-managed PSVT episodes with etripamil which reduced need for ED intervention - As in other studies, etripamil was well tolerated by patients

Intensive blood pressure treatment shown to reduce risk of this common heart disorder by more than 25%

Innovative care strategy created in response to COVID-19 pandemic emphasizes the role telemedicine plays in post-op patient monitoring